Epitel published a study demonstrating that patients with first-time seizures have a 76-fold elevated risk of neurological cancer compared to the general population.
Public source
Publisher name
Public post
Important link demonstrated in this study, between first-time seizure and elevated risk of cancer, especially neurological cancers. A 76-fold elevated risk of neurologic…
Company
Epitel
Revolutionizing how brain health is monitored.
- Industry
- Medical Equipment Manufacturing
- Location
- Salt Lake City, US
- Company size
- 51–200 employees
About Epitel
Epitel is a digital health company modernizing brain health solutions to improve seizure monitoring and detection.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Cerebrocare
Cerebrocare published a recent meta analysis confirming that sleep-deprived EEG detects epileptic activity that routine EEG often misses, leading to fewer inconclusive tests and faster answers for patients waiting on a diagnosis.
Research & Knowledge
BrainCapture
BrainCapture published a study in the Journal of Neurology & Neuropsychiatry, Neurosurgery & Psychiatry validating the wait for an EEG in a Danish multicenter ICU study.
Research & Knowledge
The Defeating Epilepsy Foundation
The Defeating Epilepsy Foundation published an article explaining why brain tumors can cause seizures, factors increasing seizure risk, and treatment for tumor-related seizures.
Research & Knowledge
Empowering Epilepsy®
Empowering Epilepsy® published an international study validating epilepsy surgery recovery and the need for continuation of care.
Research & Knowledge
CURE Epilepsy